NEW YORK (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will take a $320 million stake in the company as part of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback